Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 When will we get a new class of analgesic agent based on animal study data?

Literature DB >> 24610036

When will we get a new class of analgesic agent based on animal study data?

Tatsuo Yamamoto¹.

Abstract

Mesh：

Substances：
Bupivacaine
Ketorolac

Year: 2014 PMID： 24610036 DOI： 10.1007/s00540-014-1807-9

Source DB: PubMed Journal: J Anesth ISSN： 0913-8668 Impact factor: 2.078

Keyword Cloud
References

× No keyword cloud information.

8 in total

Review 1. Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord.

Authors: H Vanegas; H G Schaible
Journal: Prog Neurobiol Date: 2001-07 Impact factor: 11.685

2. A novel role of prostaglandin E2 in neuropathic pain: blockade of microglial migration in the spinal cord.

Authors: Shunji Kunori; Shinji Matsumura; Emiko Okuda-Ashitaka; Tayo Katano; Laurent P Audoly; Yoshihiro Urade; Seiji Ito
Journal: Glia Date: 2011-02 Impact factor: 7.452

3. Role of spinal cyclooxygenase in human postoperative and chronic pain.

Authors: James C Eisenach; Regina Curry; Richard Rauck; Peter Pan; Tony L Yaksh
Journal: Anesthesiology Date: 2010-05 Impact factor: 7.892

4. Effects of intrathecal ketorolac on human experimental pain.

Authors: James C Eisenach; Regina Curry; Chuanyao Tong; Timothy T Houle; Tony L Yaksh
Journal: Anesthesiology Date: 2010-05 Impact factor: 7.892

5. The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1.

Authors: T L Yaksh; D M Dirig; C M Conway; C Svensson; Z D Luo; P C Isakson
Journal: J Neurosci Date: 2001-08-15 Impact factor: 6.167

When will we get a new class of analgesic agent based on animal study data?

Review 1. Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord.

2. A novel role of prostaglandin E2 in neuropathic pain: blockade of microglial migration in the spinal cord.

3. Role of spinal cyclooxygenase in human postoperative and chronic pain.

4. Effects of intrathecal ketorolac on human experimental pain.

5. The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1.

6. Central nociceptive role of prostacyclin (IP) receptor induced by peripheral inflammation.

7. [Chronic refractory pain in cancer patients. Value of the spinal injection of lysine acetylsalicylate. 60 cases].

8. Intrathecal ketorolac does not improve acute or chronic pain after hip arthroplasty: a randomized controlled trial.